We only have this paper's title and publication details.
Read it at the sourceObservations reveal that interleukin 6 boosts T cell-mediated immunity to pancreatic cancer, suggesting a new therapeutic angle.
Locally high IL-6 concentrations potently enhance the T cell-mediated anti-tumor response to PDAC.
No takes yet. Share an insight, caveat, or question.
Arneson-Wissink et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: